HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Expression of glomerular plasminogen activator inhibitor type 1 in glomerulonephritis.

Abstract
Plasminogen activator inhibitor type 1 (PAI-1) and tissue plasminogen activator (tPA) are the major regulators of plasmin generation. Glomerular PAI-1/tPA balance is involved in extracellular matrix turnover, as well as fibrin deposition in glomeruli. Renal biopsy specimens were obtained from 80 patients with either primary or secondary glomerulonephritis (10 patients, minimal change nephrotic syndrome; 6 patients, focal segmental glomerulosclerosis [FSGS]; 10 patients, membranous nephropathy [MN]; 24 patients, mesangial proliferative glomerulonephritis; 15 patients, lupus nephritis; 14 patients, diabetic nephropathy; and 1 patient, membranoproliferative glomerulonephritis). We quantified glomerular PAI-1 and tPA messenger RNA (mRNA) by competitive polymerase chain reaction. We also determined PAI-1 mRNA localization by in situ hybridization. Glomerular PAI-1 mRNA levels in patients with FSGS and MN were significantly greater than those of controls. There was a sixfold increase in PAI-1-tPA mRNA ratio in patients with MN compared with the control group. In addition, glomerular PAI-1 mRNA level correlated with level of proteinuria. Conversely, there was no difference in tPA mRNA levels among types of glomerulonephritis. These results suggest that suppressed glomerular fibrinolytic and proteolytic activity may be associated with the pathogenesis of glomerulonephritis, especially in FSGS and MN.
AuthorsKazumasa Hamano, Masayuki Iwano, Yasuhiro Akai, Hiroaki Sato, Atsushi Kubo, Yoshiharu Nishitani, Hideto Uyama, Yukiko Yoshida, Masanobu Miyazaki, Hideo Shiiki, Shigeru Kohno, Kazuhiro Dohi
JournalAmerican journal of kidney diseases : the official journal of the National Kidney Foundation (Am J Kidney Dis) Vol. 39 Issue 4 Pg. 695-705 (Apr 2002) ISSN: 1523-6838 [Electronic] United States
PMID11920334 (Publication Type: Journal Article)
CopyrightCopyright 2002 by the National Kidney Foundation, Inc.
Chemical References
  • Plasminogen Activator Inhibitor 1
  • RNA, Messenger
  • Tissue Plasminogen Activator
Topics
  • Adolescent
  • Adult
  • Aged
  • Female
  • Glomerulonephritis (genetics, metabolism)
  • Glomerulonephritis, Membranous (metabolism)
  • Glomerulosclerosis, Focal Segmental (metabolism)
  • Humans
  • In Situ Hybridization
  • Male
  • Middle Aged
  • Plasminogen Activator Inhibitor 1 (biosynthesis, genetics, metabolism)
  • Polymorphism, Genetic
  • RNA, Messenger (biosynthesis, metabolism)
  • Statistics as Topic
  • Tissue Plasminogen Activator (biosynthesis, genetics, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: